AstraZeneca PLC
AstraZeneca PLC ZEG.DE Peers
See (ZEG.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZEG.DE | €118.65 | +0.00% | 188.4B | 28.19 | €4.31 | +2.25% |
| LLY.DE | €661.30 | +0.00% | 633.2B | 63.45 | €10.53 | +0.72% |
| JNJ.DE | €129.26 | +0.00% | 320.8B | 17.34 | €7.69 | +3.51% |
| 4AB.DE | €157.80 | +0.00% | 286.2B | 79.80 | €2.03 | +3.72% |
| 6MK.DE | €67.10 | +0.00% | 175.5B | 11.65 | €6.00 | +4.25% |
| AMG.DE | €237.85 | +0.00% | 127.7B | 24.90 | €9.54 | +3.56% |
| PFE.DE | €20.72 | +0.00% | 121.3B | 17.78 | €1.20 | +7.53% |
| PFE.F | €20.72 | +0.00% | 121B | 17.60 | €1.21 | +7.55% |
| GIS.DE | €94.15 | +0.00% | 117.3B | 22.79 | €4.14 | +3.11% |
| SNW.DE | €82.22 | +0.00% | 101.2B | 16.65 | €4.99 | +4.72% |
Stock Comparison
ZEG.DE vs LLY.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, LLY.DE has a market cap of 633.2B. Regarding current trading prices, ZEG.DE is priced at €118.65, while LLY.DE trades at €661.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas LLY.DE's P/E ratio is 63.45. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, ZEG.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs JNJ.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, JNJ.DE has a market cap of 320.8B. Regarding current trading prices, ZEG.DE is priced at €118.65, while JNJ.DE trades at €129.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas JNJ.DE's P/E ratio is 17.34. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, ZEG.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs 4AB.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, 4AB.DE has a market cap of 286.2B. Regarding current trading prices, ZEG.DE is priced at €118.65, while 4AB.DE trades at €157.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas 4AB.DE's P/E ratio is 79.80. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, ZEG.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs 6MK.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, 6MK.DE has a market cap of 175.5B. Regarding current trading prices, ZEG.DE is priced at €118.65, while 6MK.DE trades at €67.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas 6MK.DE's P/E ratio is 11.65. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to 6MK.DE's ROE of +0.38%. Regarding short-term risk, ZEG.DE is more volatile compared to 6MK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs AMG.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, AMG.DE has a market cap of 127.7B. Regarding current trading prices, ZEG.DE is priced at €118.65, while AMG.DE trades at €237.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas AMG.DE's P/E ratio is 24.90. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, ZEG.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs PFE.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, PFE.DE has a market cap of 121.3B. Regarding current trading prices, ZEG.DE is priced at €118.65, while PFE.DE trades at €20.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas PFE.DE's P/E ratio is 17.78. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, ZEG.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs PFE.F Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, PFE.F has a market cap of 121B. Regarding current trading prices, ZEG.DE is priced at €118.65, while PFE.F trades at €20.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas PFE.F's P/E ratio is 17.60. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, ZEG.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs GIS.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, GIS.DE has a market cap of 117.3B. Regarding current trading prices, ZEG.DE is priced at €118.65, while GIS.DE trades at €94.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas GIS.DE's P/E ratio is 22.79. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, ZEG.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs SNW.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, SNW.DE has a market cap of 101.2B. Regarding current trading prices, ZEG.DE is priced at €118.65, while SNW.DE trades at €82.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas SNW.DE's P/E ratio is 16.65. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, ZEG.DE is less volatile compared to SNW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs BRM.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, BRM.DE has a market cap of 82.9B. Regarding current trading prices, ZEG.DE is priced at €118.65, while BRM.DE trades at €39.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas BRM.DE's P/E ratio is 17.49. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, ZEG.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs BAYN.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, BAYN.DE has a market cap of 26B. Regarding current trading prices, ZEG.DE is priced at €118.65, while BAYN.DE trades at €25.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas BAYN.DE's P/E ratio is -7.97. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, ZEG.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs BAYN.SG Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, BAYN.SG has a market cap of 25.9B. Regarding current trading prices, ZEG.DE is priced at €118.65, while BAYN.SG trades at €25.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, ZEG.DE is more volatile compared to BAYN.SG. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs IDP.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, IDP.DE has a market cap of 15.5B. Regarding current trading prices, ZEG.DE is priced at €118.65, while IDP.DE trades at €107.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas IDP.DE's P/E ratio is 12.18. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, ZEG.DE is more volatile compared to IDP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs GS7.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 188.4B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, ZEG.DE is priced at €118.65, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.19, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, ZEG.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.